Used in pharmaceutical research as a key intermediate in the synthesis of kinase inhibitors, particularly those targeting cancer pathways. Its structure enables selective binding to enzyme active sites, enhancing drug potency. Commonly employed in the development of targeted therapies for oncology, especially in compounds aimed at treating solid tumors. Also utilized in medicinal chemistry for scaffold modification to improve metabolic stability and bioavailability of lead compounds.